Perbedaan UBC Medical Indonesia Tbk. dan Summarecon Agung Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Summarecon Agung Tbk. diperdagangkan di Rp298 (kapitalisasi pasar 4,79 T, volume 24 jam 12,25 jt). Perbedaan utamanya: Summarecon Agung Tbk. jauh lebih besar — sekitar 8,3× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Summarecon Agung Tbk. lebih aktif diperdagangkan (12,25 jt vs 3,48 jt). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | SMRA | |
|---|---|---|
Kapitalisasi Pasar | 576,7 M | 4,79 T |
Volume | 3,48 jt | 12,25 jt |
Lot | 34,82 rb | 122,47 rb |
Perputaran | 522,79 jt | 3,62 M |
Harga Rata-rata | 150,13 | 295,63 |
Nilai Transaksi | 522,79 jt | 3,62 M |
Harga Ekuilibrium Indikatif | 148 | 298 |
Volume Ekuilibrium Indikatif | 350 | 2,11 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Summarecon Agung Tbk (the Company) was established within the framework of the Domestic Capital Investment Law based on notarial deed No. 308 dated November 26, 1975 of Ridwan Suselo, S.H. PT. Summarecon Agung Tbk is one of the nation`s leading township developers. Entering its twenty-forth year, the original 10-hectare landbank it started with has turned into a vibrant, 500 hectare township in North Jakarta where commercial vivacity peacefully coexists with its houses numbering in the tens of thousands.
Selengkapnya di halaman SMRA →